Aldeyra Therapeutics, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 791 | 0.0% | 152,787 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 785 | 0.0% | 150,478 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 603 | 0.0% | 157,538 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 793 | 0.0% | 137,985 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 682 | 0.0% | 136,733 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 737 | 0.0% | 136,733 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 453 | 0.0% | 136,733 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 410 | 0.0% | 125,525 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 441 | 0.0% | 125,525 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 839 | 0.0% | 125,525 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 1,053 | 0.0% | 125,525 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 220 | 0.0% | 22,201 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 155 | 0.0% | 22,201 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 119 | 0.0% | 22,201 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 89 | 0.0% | 22,201 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 591 | 0.0% | 132,908 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 514 | 0.0% | 128,385 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 1,095 | 0.0% | 124,686 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,418 | 0.0% | 125,099 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 216 | 0.0% | 18,127 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 125 | 0.0% | 18,127 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 135 | 0.0% | 18,127 | 9/30/2020 |
| 2020 Q1 | 5/15/2020 | 131 | 0.0% | 52,683 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 335 | 0.0% | 57,647 | 12/31/2019 |